Gaponov, D.P.,
Khafizov, T.N.,
Kochkina, K.V.,
Chernov, I.I.,
Enginoev, S.T.,
Shaposhnikova, E.I. (2022) access group 2 (4,2%) patients developed access-
related complications-acute thrombosis of the common
Zagidullin, N,
Ruslan, G,
Anton, T,
Paruir, D,
Sergey, D,
Irina, L,
Valentin, P (2022) SERUM BIOMARKERS IN
MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA
Motloch, LJ;,
Jirak, P;,
Gareeva, D;,
Davtyan, P;,
Gumerov, R;,
Lakman, I;,
Tataurov, A;,
Zulkarneev, R;,
Kabirov, I;,
Cai, BZ;,
Valeev, B;,
Pavlov, V;,
Kopp, K;,
Hoppe, UC;,
Lichtenauer, M;,
Fiedler, L;,
Pistulli, R;,
Zagidullin, N (2022) -discharge
mortality of patients with COVID-19 pneumonia.
Methods: Serum soluble ST2, VCAM-1, and hs-TnI were
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) diseases with a high rate of
mortality in patients with SSDs. Neuropeptide Y receptor Y5 (NPY5R) is known
Yanchao, L.,
Sibin, Z.,
Gareev, I.,
Huan, X.,
Junfei, Z.,
Chunyang, L.,
Beylerli, O.,
Sufianov, A.,
Chao, Y.,
Yuyan, G.,
Xun, X.,
Ahmad, A. (2022) tools, we present the causes of COVID-19 infection leading to increased
mortality in carotid
Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) related toxicity. Immune-
related adverse events (irAEs) are a major cause of immune checkpoint inhibitors